Publicaciones en colaboración con investigadores/as de Assistance Publique -Hopitaux De Paris (12)

2026

  1. Derivation and Validation of a COPD-Specific Pulmonary Embolism Diagnostic Strategy

    Thrombosis and Haemostasis, Vol. 126, Núm. 5, pp. 509-517

2025

  1. Acute pulmonary embolism: A multimarker calculator to predict short-term outcomes

    European Heart Journal, Vol. 46, Núm. 45, pp. 4921-4929

  2. Venous thromboembolism in patients aged ≥90 years: Trends in clinical features, treatment, and outcomes—RIETE registry

    Journal of the American Geriatrics Society, Vol. 73, Núm. 4, pp. 1219-1226

2024

  1. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  2. Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy

    AIDS (London, England), Vol. 38, Núm. 7, pp. 983-991

  3. The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)

    American journal of respiratory and critical care medicine, Vol. 210, Núm. 1, pp. 119-127

2023

  1. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

2022

  1. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

    HIV Medicine, Vol. 23, Núm. 6, pp. 585-598

2021

  1. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

    The Lancet Infectious Diseases, Vol. 21, Núm. 9, pp. 1313-1323

2020

  1. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 22, Núm. 2, pp. 181-195

  2. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study

    The Lancet HIV, Vol. 7, Núm. 11, pp. e740-e751

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180